Celleric
Our commitment to faster
genetic diagnosis in the
COVID-19 outbreak.
Accompanying the measures indicated by international authorities to contain the spread of the COVID-19 virus and guided by our mission to provide genetic and oncological results faster, we are at full disposal of all the health centers that are fighting this pandemic. Our Artificial Intelligence-based platform, Vali, serves in drastically reducing delivery times of cytogenetic studies, frequently made by the same professionals needed today to test and diagnose COVID-19 cases. Moreover, it enables to work remotely from home, helping to keep the required social distancing. At Celleric, we hope our platform could help to free those increasingly needed professionals faster, to optimize resources within the main diagnostic areas.